Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia |
Boston Children’s Hospital / Samantha Morris, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma |
Columbia University Medical Center / Darrell Yamashiro, MD, PhD |
Innovation Grants |
2013 |
New York |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers |
Dana-Farber Cancer Institute / Charles Roberts, MD, PhD |
Innovation Grants |
2013 |
Massachusetts |
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University / Letterio, John MD & Matloub, Yousif MD |
Phase I/II Infrastructure Grants |
2013 |
Ohio |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |
Nitrosative Stress And Symptom Severity During Childhood Leukemia Treatment |
Duke University Medical Center / Marilyn Hockenberry, RN, PhD |
Nurse Researcher Grants |
2013 |
North Carolina |
Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia
|
Massachusetts General Hospital / David Langenau, PhD |
Innovation Grants |
2013 |
Massachusetts |
Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy |
Palmetto Health / Janice Withycombe, PhD |
Nurse Researcher Grants |
2013 |
South Carolina |
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
|
Duke University Medical Center / Gerard Blobe, MD, PhD |
Reach Grants |
2013 |
North Carolina |